Can you take codeine with Mounjaro — and what should you know first?

Mounjaro slows gastric emptying, which can change the timing of absorption for oral medicines taken at the same time.
Codeine is an opioid analgesic that is itself absorbed via the gut and is affected by changes in stomach-emptying speed.
This is not a blanket interaction that makes codeine unsafe, but it is something your prescriber should be aware of before you take both.
You can check the Mounjaro Patient Information Leaflet (the interaction section lists medicinal products where gastric-emptying effects are relevant) in under a minute by searching for it on the Mounjaro SmPC on the eMC.

Taking codeine alongside Mounjaro isn't straightforwardly banned, but it does need careful thought. Because Mounjaro (tirzepatide) slows how quickly the stomach empties, it can alter the rate at which oral medicines (including opioids like codeine) are absorbed into your system. That doesn't automatically mean the two cannot be used together, but it does mean your prescriber needs to know. These are prescription-only medicines, and suitability is always a clinical decision made with your full medication history in front of a qualified professional. If you're already taking tirzepatide and you're wondering how to handle a codeine prescription, or you're about to start Mounjaro and rely on codeine for pain management, the guidance below explains what the evidence shows and what to ask your GP or pharmacist.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the interaction means in practice — and when to speak to a clinician

How does Mounjaro affect the way oral medicines are absorbed?

Tirzepatide works, in part, by slowing the passage of food and liquid through the stomach. This is one of the mechanisms behind the appetite reduction people on Mounjaro often notice early in treatment. It's also the mechanism that creates a meaningful question about any oral medicine you swallow at the same time. When stomach-emptying slows, the window between swallowing a tablet or capsule and it reaching the small intestine (where most absorption happens) can lengthen. For some medicines that delay is irrelevant. For others, particularly those where the timing of peak concentration matters, it is not.

The NHS medicines page for tirzepatide notes this effect explicitly, and the Mounjaro Summary of Product Characteristics (SmPC) lists gastric-emptying delay as a pharmacodynamic property that prescribers should factor into co-prescribing decisions. The practical takeaway: Mounjaro does not chemically block other medicines, but it can push their absorption later than the manufacturer's original studies assumed.

For medicines with a wide therapeutic window (where the difference between a slightly lower peak and a slightly higher one doesn't change much clinically) this rarely matters. For medicines where timing is more sensitive, it warrants a conversation. Codeine sits in the second category, and that's worth unpacking.

Why does codeine specifically raise the question?

Codeine is an opioid analgesic and cough suppressant. After you swallow it, codeine is absorbed in the gut and then converted in the liver to morphine, which carries most of its pain-relieving effect. The speed of that first step (gut absorption) is what gastric emptying influences. If absorption is slower or more drawn out because Mounjaro is slowing the stomach, the onset of pain relief may be delayed and the concentration profile across the dosing interval can change.

There is also a secondary consideration. Both opioids and GLP-1/GIP medicines influence gut motility in their own ways. Opioids are well known to cause constipation and can slow the gut independently. Add tirzepatide's gastric-slowing effect and some people notice their GI side effects (constipation in particular) become more pronounced. This isn't always the case, and it's not a pharmacokinetic interaction in the classical sense, but it's a comfort and tolerability issue worth raising with whoever manages your pain or your weight treatment.

None of this means the combination is prohibited. It means it should be managed with awareness. If you're looking at the broader picture of how other medicines sit alongside tirzepatide, our guide to taking GLP-1 medicines alongside Mounjaro covers that angle in more detail.

What should you actually do if you need to take both?

The practical steps are straightforward even if the pharmacology sounds complex. First, tell your Mounjaro prescriber about every medicine you take regularly, including codeine, whether it's prescribed or bought over the counter. This is not a formality. A prescriber who doesn't know your full list cannot make a fully informed clinical decision. Second, if codeine is being prescribed by a GP or hospital team who may not know you're on tirzepatide, tell them. A quick mention takes less than thirty seconds and can prevent a dosing decision being made on incomplete information.

If you're managing occasional pain with over-the-counter codeine products, it's worth asking a pharmacist whether an alternative analgesic (paracetamol, for instance, or an anti-inflammatory if appropriate) might serve you just as well without the gastric-motility overlap. Paracetamol's absorption can also be affected by delayed gastric emptying to a degree, but for simple short-term pain relief, your pharmacist can weigh that up with you on the spot.

One practical habit: before starting any new medicine or pain remedy while you're on Mounjaro, spend a minute on the Mounjaro SmPC on the eMC and check the interactions section. It's written for professionals but the relevant entries are readable, and it tells you what Eli Lilly's clinical team flagged in their own studies.

People on Mounjaro with ongoing or complex pain conditions (those using codeine regularly, or taking higher-strength formulations) should have a dedicated review with their GP or pain specialist, and our detailed guide to codeine and Mounjaro is a useful resource to read before that appointment. Managing pain effectively while on a weight-management medicine is entirely possible; it just needs the full picture in front of the right clinician. For more on living with other conditions alongside Mounjaro treatment, the discussion of IBS and Mounjaro covers how gut-related conditions intersect with tirzepatide.

Are there any situations where the combination needs extra caution?

A few specific situations are worth naming clearly. If you're on regular, higher-dose codeine for chronic pain, the interaction with gastric emptying is more clinically relevant than for someone taking a single low-dose tablet after a dental procedure. Your pain-management plan may need reviewing alongside your tirzepatide titration, particularly as doses increase and the gastric-emptying effect can become more pronounced at higher strengths.

People who develop significant nausea, vomiting or severe constipation on tirzepatide (side effects the NHS tirzepatide page describes as the most commonly reported) should be especially careful about adding an opioid into that picture, since codeine-related constipation stacks on top. Dehydration from vomiting is a separate concern worth monitoring, and if you're feeling unwell more broadly, our page on taking Mounjaro when you have flu explains how illness can affect your treatment.

Pregnancy, breastfeeding, or planning to conceive: neither Mounjaro nor codeine is recommended in these circumstances, and combining them is not appropriate. Under-18s are not licensed for Mounjaro at all.

If you have questions about how HRT interacts with tirzepatide (a related query that often comes up for women managing multiple medications) you'll find that covered on our Mounjaro and HRT page. And if you'd like to understand the tirzepatide medicine in full before starting, our tirzepatide overview is a good starting point.

If you're ready to discuss your full medication history with a qualified prescriber and explore whether Mounjaro is suitable for you, you can start your free consultation with our clinical team today.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions